Results from the EMPULSE Trial - report from ACC2022

from Medical Digest & Congress Report · host Medical Congress News

Professor Mikhail Kosiborod going to speaking about the additional analysis from the EMPULSE trial that were presented at the American College of Cardiology congress. The trial demonstrated the effects of empagliflozin on symptoms, physical limitations and quality of life in patients hospitalized for acute heart failure. Video: https://congressreport.eu/scientific-contents/interview:results-empulse-trial

Episode metadata supplied by the publisher feed · Published Apr 20, 2022

Embed this episode

Attribution link and audio player

NOW PLAYING

Results from the EMPULSE Trial - report from ACC2022

0:00 9:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Medical Digest & Congress Report?

This episode is 9 minutes long.

When was this Medical Digest & Congress Report episode published?

This episode was published on April 20, 2022.

Can I download this Medical Digest & Congress Report episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!